Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cost Plus Drugs vs Medical Health Institute

Cost Plus Drugs
Graded #370

Higher grade

vs+5.200000000000003
Medical Health Institute
Graded #469

Lower grade

The verdict

Cost Plus Drugs takes it — 58.5/100 to 53.3/100.

Cost Plus Drugs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mark Cuban's transparent-pricing online pharmacy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationCost Plus Drugs +25
65
40
Clinical oversightMedical Health Institute +2
67
69
Labs & monitoringMedical Health Institute +1
51
52
FulfillmentCost Plus Drugs +6
73
67
Contract termsEven
55
55
Cost Plus Drugs · left barMedical Health Institute · right bar

The numbers

MetricCost Plus DrugsMedical Health Institute
WeighScore58.5/10053.3/100
GradeCC
Scorecard rank#370#469
Semaglutide$279/mo (brand Ozempic)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Cost Plus Drugs

Graded #370 · C

Strengths

  • Transparent pricing: wholesale cost + 15% markup + $5 pharmacy fee, the same for everyone
  • Around $279/mo for branded Ozempic — well below typical retail list prices
  • Mark Cuban's PBM-disrupting pharmacy, praised by Forbes Health, Wired, and KFF Health News
  • Ships to all 50 states; genuine FDA-approved Novo Nordisk Ozempic, not compounded
  • Partnered with 9amHealth so you can get prescribed and fill at Cost Plus pricing

Where it loses points

  • Fulfillment only — no telehealth intake; you need a prescription from an outside clinician
  • Ozempic is FDA-indicated for type 2 diabetes, not weight management — weight-loss use is off-label
  • Wegovy availability has been spotty — check current stock before assuming it ships
  • No compounded semaglutide or tirzepatide — brand only
  • No clinical follow-up — side-effect monitoring falls to your prescribing clinician
Medical Health Institute

Graded #469 · C

Strengths

  • Operating entity disclosed: Medical Health Institute, LLC, with full Pinecrest, FL address and phone
  • Named medical director (Amy Wecker, MD) plus four more named clinicians on the about page
  • Three care pathways with starting-price anchors: $99 TRT / $129 peptides / $149 weight-loss
  • LegitScript Certified with a footer verification link
  • HIPAA compliance claimed

Where it loses points

  • GLP-1 medication options (semaglutide vs tirzepatide; compounded vs brand) not shown — gated behind the intake funnel
  • Pharmacy partner not named — only generic 'FDA-regulated facilities' language
  • State availability not disclosed
  • Several subpages (/weight-loss, /pricing, /products, /faq) returned server errors during verification
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard